Related Experiment Video

Updated: Mar 3, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.4K

Heart Failure Guidelines on Pharmacotherapy

Lampros Papadimitriou1, Carine E Hamo2, Javed Butler2

  • 1Division of Cardiology, Stony Brook Medicine, Health Sciences Center T-16, Room 080, Stony Brook, NY, 11794, USA. lampros.papadimitriou@stonybrookmedicine.edu.

Handbook of Experimental Pharmacology
|April 29, 2017
PubMed

Insights

Heart Failure (HF) significantly impacts public health, affecting millions and incurring substantial costs. This review details medications proven to reduce mortality and morbidity in HF patients, referencing North American guidelines.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Heart Failure (HF) presents a significant public health challenge, particularly in high-income nations.
  • Over 6 million adults in the USA are affected by HF, incurring substantial healthcare costs and high mortality rates.
  • Despite therapeutic advancements, HF remains a major burden on healthcare systems.

Purpose of the Study:

  • To review medications proven to reduce mortality and morbidity in Heart Failure patients.
  • To align with the latest North American Heart Failure guidelines.
  • To compare current recommendations with the 2016 European Society of Cardiology guidelines.

Main Methods:

  • Literature review of medications for Heart Failure.
  • Analysis based on North American Heart Failure guidelines.
  • Comparative analysis of North American and European Society of Cardiology guidelines.

Main Results:

  • Identified key medications significantly reducing mortality and morbidity in HF patients.
  • Highlighted adherence to North American Heart Failure guidelines.
  • Provided a comparative overview of guideline recommendations.

Conclusions:

  • Specific medications are crucial for managing Heart Failure and improving patient outcomes.
  • Guidelines from North America and Europe offer valuable, comparable strategies for HF management.
  • Continued adherence to evidence-based guidelines is essential for mitigating the impact of Heart Failure.

Keywords:
GuidelinesHFrEFHeart failureStage C

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.1K
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.1K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
431
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
479
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
600
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551